Global Urolithiasis Management Devices Market, by Product Type (Shockwave lithotripter (Intracorporeal Lithotripter, Extracorporeal Lithotripter), and Ureterorenoscope (Rigid Ureterorenoscope, Semi Rigid Ureterorenoscope, Flexible Ureterorenoscope)) by End Users (Hospitals, Clinics, Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,694.7 Million in 2023 and is expected to exhibit a CAGR of 4.8% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Increase in organic strategies such as regulatory authority clearance for the urolithiasis management device to the market players is expected to drive the global urolithiasis management devices market by the forecast period. For instance, on February 3, 2023, Boston Scientific Corporation, a biomedical devices manufacturer announced that the company received U.S. Food and Drug Administration FDA’s clearance for LithoVue Elite single-use digital flexible ureteroscope, a device used to visualize and treat the stone, for the treatment of urinary disorders.
Global Urolithiasis Management Devices Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
Furthermore, healthcare providers were facing challenges in terms of additional manpower, equipment, consumables, and other resources which were required to ensure safety in hospitals and provide treatment to patients and devices to the ambulatory surgical centers. This has impacted the overall healthcare market negatively.
During the COVID-19 pandemic, the urolithiasis management device market was significantly impacted due to an increase in the demand for treatment options for kidney stone-related disease and a decrease in the supply of devices to treat urolithiasis due to restrictions imposed by the government during COVID-19. For instance, in October 2020, data was published by Elsevier, a academic publishing company, according to which, urolithiasis emergency admissions have decreased significantly in Rome during the COVID-19 epidemic. Individuals who were admitted to the emergency department had greater difficulties, required hospitalization more frequently, and early stone removal was preferable over simple urine drainage in terms of clinical care.
Global Urolithiasis Management Devices Market: Key Developments
In June 2020, Olympus Corporation, a manufacturer of optical and digital precision technology, launched the Soltive SuperPulsed Laser System (Soltive Laser System), a new application of thulium fiber laser technology designed for stone lithotripsy and soft tissue applications.
Increase in research and development activities by research centers, for instance, in October 2021, UW medical center, a research center that conducts kidney stone research at a treatment center in northwest Seattle U.S., investigated the capacity of ultrasonic waves to move and remove tiny surgical debris so that it can be naturally evacuated.
Browse 22 Market Data Tables and 14 Figures spread through 150 Pages and in-depth TOC on “Global Urolithiasis Management Devices Market”- Forecast to 2030, by Product Type (Shockwave Lithotripter, Intracorporeal Lithotripter, Extracorporeal lithotripter), and Ureterorenoscope (Rigid Ureterorenoscope, Semi Rigid Ureterorenoscope, Flexible Ureterorenoscope)) by End User (Hospital, Clinics, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/urolithiasis-management-devices-market-1684
Key Takeaways of the Global Urolithiasis Management Devices Market:
- Major players in the global urolithiasis management devices market are focused on launching new products for expanding their product portfolio. For instance, in July 2020, Lumenis Be Ltd., an energy-based medical solution-providing company, launched MOSES 2.0, the next-generation holmium laser technology for the treatment of urolithiasis.
- Among product type shock wave lithotripter held a dominant position in the Europe region due to the results obtained from analysis of Shock wave lithotripsy, for the treatment of kidney stones. For instance, in June 2020, the European Journal of Medical Research published data, according to which a prospective clinical pilot study was conducted to evaluate the efficacy of shock wave lithotripter for the treatment of kidney stones, significant (p ≤ 0.05) changes were observed in several blood parameters after Shock Wave Lithotripsy (SWL) procedure and significantly increased in the concentration of Neutrophil gelatinase-associated lipocalin (NGAL) was observed.
- Major players which are operating in the global urolithiasis management devices market include, Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc., Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Potent Medical., Applaud Medical, Inc., and other prominent players.
